Univariate Analysis: All Patients
| . | OS . | EFS . |
|---|---|---|
| . | P . | P . |
| Limited initial stage | NS | NS |
| No B symptoms initially | NS | NS |
| Duration of remission >12 mo | NS | <.01 |
| No prior radiotherapy | NS | .04 |
| No relapse in irradiated site | NS | NS |
| No extranodal sites at relapse | .14 | NS |
| No B symptoms at relapse | <.01 | .02 |
| Limited stage at relapse | NS | NS |
| CR/MD to cytoreductive/salvage therapy | <.01 | <.01 |
| High-dose therapy at relapse | NS | <.01 |
| . | OS . | EFS . |
|---|---|---|
| . | P . | P . |
| Limited initial stage | NS | NS |
| No B symptoms initially | NS | NS |
| Duration of remission >12 mo | NS | <.01 |
| No prior radiotherapy | NS | .04 |
| No relapse in irradiated site | NS | NS |
| No extranodal sites at relapse | .14 | NS |
| No B symptoms at relapse | <.01 | .02 |
| Limited stage at relapse | NS | NS |
| CR/MD to cytoreductive/salvage therapy | <.01 | <.01 |
| High-dose therapy at relapse | NS | <.01 |
NS: P > .20.